Journal of Sabzevar University of Medical Sciences

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

Peer Review Process

News

Journal Forms

Paper Preparation Guide

Guide to Writing a Policy Brief

Brief Policy form

Evaluation of the Indications, Effectiveness, and Outcomes of Uterine Artery Embolization in Patients with Abnormal Uterine Bleeding or Postpartum Hemorrhage at Shahid Tajrish Hospital from 2019 to 2022

Document Type : Original Article

Authors

1 School of Medicine, Isfahan University of Medical Science, Isfahan , Iran

2 Department of Radiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran

3 Assisstant professor of Radiology ,Shahid Beheshti University of Medical Sciences, Shohadaye Tajrish Hospital,Tehran, Iran.

Abstract

Introduction: This study aimed to evaluate the effectiveness of uterine artery embolization (UAE) in controlling fibroid-related abnormal uterine bleeding (AUB) and to assess its impact on fertility preservation and patient satisfaction.
Materials and Methods: This retrospective studyincluded 17 women aged 21-42 years who underwent UAE between 2019 and 2022 at Shohada Tajrish Hospital. Data on demographic, menstrual patterns, number of children, length of hospital stay, complications, and post-treatment fertility status were collected from medical records. Patients were followed for 3 to 12 months through in-person visits or phone calls. Data were analyzed with descriptive and inferential statistical tests using SPSS version 25. (P<0.05).
Results: Uterine fibroids were the cause of AUB (100%). The most common bleeding pattern was menorrhagia (47.1%), followed by normal menstruation (41.2%), menopause (5.9%), and metrorrhagia (5.9%). Most patients (54.2%) had two children. Most patients (64.7%) were discharged within 24 hours, while 35.3% were discharged within 48 hours. Fever was the most frequent post-procedure complication (41.2%). All patients preserved their menstruation. All patients reported preserved menstrual function at follow-up.
Conclusion: Uterine artery embolization (UAE) proved to be a safe and effective treatment for fibroid-related abnormal uterine bleeding (AUB) in this study, with preservation of menstrual function observed throughout the 3–12-month follow-up period. These findings suggest that UAE may be a suitable uterus-preserving alternative to surgery. However, these results should be interpreted with caution due to the study's retrospective design and small sample size. Larger prospective studies are warranted to confirm these outcomes.

Keywords

Main Subjects

References
  1. Lasmar RB, Lasmar BP. The role of leiomyomas in the genesis of abnormal uterine bleeding (AUB). Best Pract Res Clin Obstet Gynaecol. 2017;40:82-8. DOI: 10.1016/j.bpobgyn.2016.09.008.
  2. Brenner PF. Differential diagnosis of abnormal uterine bleeding. Am J Obstet Gynecol. 1996;175(3 Pt 2):766-9. DOI: 1016/s0002-9378(96)80082-2
  3. Tsakiridis I, Giouleka S, Koutsouki G, Kostakis N, Kalogiannidis I, Kourtis A, et al. Investigation and management of abnormal uterine bleeding in reproductive-aged women: a descriptive review of national and international recommendations. Eur J Contracept Reprod Health Care. 2022;27(6):504-17. DOI: 1080/13625187.2022.2112169
  4. Munro MG, Critchley HO, Broder MS, Fraser IS. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3-13؛ و DOI: 10.1016/j.ijgo.2010.11.011
  5. Oyelese Y, Ananth CV. Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol. 2010;53(1):147-56. DOI: 10.1097/GRF.0b013e3181cc406d
  6. Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007;142(1):20-5. DOI: 10.1016/j.surg.2007.02.001
  7. Ende HB, Lozada MJ, Chestnut DH, Osmundson SS, Walden RL, Shotwell MS, et al. Risk Factors for Atonic Postpartum Hemorrhage: A Systematic Review and Meta-analysis. Obstet Gynecol. 2021;137(2):305-23 DOI: 10.1097/AOG.0000000000004228.
  8. Farhana M, Tamura N, Mukai M, Ikuma K, Koumura Y, Furuta N, et al. Histological characteristics of the myometrium in the postpartum hemorrhage of unknown etiology: a possible involvement of local immune reactions. J Reprod Immunol. 2015;110:74-80. DOI: 10.1016/j.jri.2015.04.004
  9. Grotegut CA, Paglia MJ, Johnson LN, Thames B, James AH. Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony. Am J Obstet Gynecol. 2011;204(1):56.e1-6. DOI: 10.1016/j.ajog.2010.08.023
  10. Moss JG, Cooper KG, Khaund A, Murray LS, Murray GD, Wu O, et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. Bjog. 2011;118(8):936-44.
  11. Lee HJ, Cho HY, Peck MJ, Ki HJ, Moon MJ, Kim HC, et al. Uterine artery embolization versus cesarean hysterectomy in the management of postpartum hemorrhage. Minim Invasive Ther Allied Technol. 2019;28(6):351-8. DOI: 10.1111/j.1471-0528.2011.02952.x
  12. Aoki M, Tokue H, Miyazaki M, Shibuya K, Hirasawa S, Oshima K. Primary postpartum hemorrhage: outcome of uterine artery embolization. Br J Radiol. 2018;91(1087):20180132. DOI: 10.1259/bjr.20180132
  13. Kim MD, Kim S, Kim NK, Lee MH, Ahn EH, Kim HJ, et al. Long-term results of uterine artery embolization for symptomatic adenomyosis. AJR Am J Roentgenol. 2007;188(1):176-81. DOI: 10.2214/AJR.05.1613
  14. Kim T, Shin JH, Kim J, Yoon HK, Ko GY, Gwon DI, et al. Management of bleeding uterine arteriovenous malformation with bilateral uterine artery embolization. Yonsei Med J. 2014;55(2):367-73. DOI: 10.3349/ymj.2014.55.2.367
  15. Ukybassova T, Terzic M, Dotlic J, Imankulova B, Terzic S, Shauyen F, et al. Evaluation of Uterine Artery Embolization on Myoma Shrinkage: Results from a Large Cohort Analysis. Gynecol Minim Invasive Ther. 2019;8(4):165-71. DOI: 10.4103/GMIT.GMIT_50_19
  16. Chen Y, Wang G, Xie F, Wang B, Tao G, Kong B. Embolization of uterine arteriovenous malformation. Iran J Reprod Med. 2013;11(2):159-66. PMCID: PMC3941356.
  17. Heikinheimo O, Fraser I. The current status of hormonal therapies for heavy menstrual bleeding. Best Pract Res Clin Obstet Gynaecol. 2017;40:111-20. DOI: 10.1016/j.bpobgyn.2017.01.001
  18. Heikinheimo O, Fraser I. The current status of hormonal therapies for heavy menstrual bleeding. Best Pract Res Clin Obstet Gynaecol. 2017;40:111-20. DOI: 10.1016/j.bpobgyn.2017.01.001
  19. Sun Y, Wang Y, Mao L, Wen J, Bai W. Prevalence of abnormal uterine bleeding according to new International Federation of Gynecology and Obstetrics classification in Chinese women of reproductive age: A cross-sectional study. Medicine (Baltimore). 2018;97(31):e11457. DOI: 10.1097/MD.0000000000011457
  20. Tanchuling JL. 1158 Prevalence of endometrial carcinoma in women with myoma uteri associated abnormal uterine bleeding (AUB) in a tertiary government hospital2021. A140.2-A2 p. DOI:10.1136/ijgc-2021-ESGO.234
  21. Clark TJ, Stevenson H. Endometrial Polyps and Abnormal Uterine Bleeding (AUB-P): What is the relationship, how are they diagnosed and how are they treated? Best Pract Res Clin Obstet Gynaecol. 2017;40:89-104. DOI: 10.1016/j.bpobgyn.2016.09.005
  22. Clark TJ, Middleton LJ, Cooper NA, Diwakar L, Denny E, Smith P, et al. A randomised controlled trial of Outpatient versus inpatient Polyp Treatment (OPT) for abnormal uterine bleeding. Health Technol Assess. 2015;19(61):1-194. DOI: 10.3310/hta19610
  23. Bourdel N, Chauvet P, Tognazza E, Pereira B, Botchorishvili R, Canis M. Sampling in Atypical Endometrial Hyperplasia: Which Method Results in the Lowest Underestimation of Endometrial Cancer? A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2016;23(5):692-701. DOI: 10.1016/j.jmig.2016.03.017
  24. Dreisler E, Stampe Sorensen S, Ibsen PH, Lose G. Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years. Ultrasound Obstet Gynecol. 2009;33(1):102-8. DOI: 10.1002/uog.6259
  25. Lieng M, Istre O, Qvigstad E. Treatment of endometrial polyps: a systematic review. Acta Obstet Gynecol Scand. 2010;89(8):992-1002 DOI: 10.3109/00016349.2010.493196.
  26. Abbott JA. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017;40:68-81. DOI: 10.1016/j.bpobgyn.2016.09.006
  27. Deligeoroglou E, Karountzos V. Abnormal Uterine Bleeding including coagulopathies and other menstrual disorders. Best Pract Res Clin Obstet Gynaecol. 2018;48:51-61. DOI: 10.1016/j.bpobgyn.2017.08.016
  28. Kourani A, Daher N. Leveraging PID Gain Selection Towards Adaptive Backstepping Control for a Class of Second-Order Systems2021. 1174-9 p. DOI:10.23919/ACC50511.2021.9483159
  29. Duhan N. Current and emerging treatments for uterine myoma - an update. Int J Womens Health. 2011;3:231-41. DOI: 10.2147/IJWH.S15710
  30. Sparic R, Mirkovic L, Malvasi A, Tinelli A. Epidemiology of Uterine Myomas: A Review. Int J Fertil Steril. 2016;9(4):424-35 DOI: 10.22074/ijfs.2015.4599.
  31. Cramer SF, Horiszny JA, Leppert P. Epidemiology of uterine leiomyomas. With an etiologic hypothesis. J Reprod Med. 1995;40(8):595-600 PMID: 7473458.
  32. Su WH, Lee WL, Cheng MH, Yen MS, Chao KC, Wang PH. Typical and atypical clinical presentation of uterine myomas. J Chin Med Assoc. 2012;75(10):487-93. DOI: 10.1016/j.jcma.2012.07.004
  33. Török P, Póka R. [Diagnosis and treatment of uterine myoma]. Orv Hetil. 2016;157(21):813-9. DOI: 10.1556/650.2016.30435.
  34. . Kim TJ, Shin SJ, Kim TH, Cho CH, Kwon SH, Seong SJ, et al. Multi-institution, Prospective, Randomized Trial to Compare the Success Rates of Single-port Versus Multiport Laparoscopic Hysterectomy for the Treatment of Uterine Myoma or Adenomyosis. J Minim Invasive Gynecol. 2015;22(5):785-91. DOI: 10.1016/j.jmig.2015.02.022
  35. . Sparic R, Terzic M, Malvasi A, Tinelli A. Uterine fibroids - clinical presentation and complications. Acta chirurgica iugoslavica. 2014;61:41-8. DOI:10.2298/ACI1403041S
  36.  Ahdad-Yata N, Fernandez H, Nazac A, Lesavre M, Pourcelot AG, Capmas P. [Fertility after hysteroscopic resection of submucosal myoma in infertile women]. J Gynecol Obstet Biol Reprod (Paris). 2016;45(6):563-70. DOI: 10.1016/j.jgyn.2015.06.028
  37.  Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril. 2017;108(3):416-25. DOI: 10.1016/j.fertnstert.2017.06.034
  38. Gupta JK, Sinha A, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2012(5):Cd005073. DOI: 10.1002/14651858.CD005073.pub3
  39.  Goodwin SC, McLucas B, Lee M, Chen G, Perrella R, Vedantham S, et al. Uterine artery embolization for the treatment of uterine leiomyomata midterm results. J Vasc Interv Radiol. 1999;10(9):1159-65. DOI: 10.1016/s1051-0443(99)70213-7
  40.  Spencer EB, Stratil P, Mizones H. Clinical and periprocedural pain management for uterine artery embolization. Semin Intervent Radiol. 2013;30(4):354-63. DOI: 10.1055/s-0033-1359729
  41.  Rajan DK, Beecroft JR, Clark TW, Asch MR, Simons ME, Kachura JR, et al. Risk of intrauterine infectious complications after uterine artery embolization. J Vasc Interv Radiol. 2004;15(12):1415-21. DOI: 10.1097/01.RVI.0000141337.52684.C4
Journal of Sabzevar University of Medical Sciences
Volume 32, Issue 6
January and February 2026
Pages 781-792
Files
History
  • Receive Date: 07 March 2025
  • Revise Date: 30 August 2025
  • Accept Date: 07 September 2025
Share
How to cite
Statistics